BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29165384)

  • 1. Solid Lipid Nanoparticles of Albendazole for Enhancing Cellular Uptake and Cytotoxicity against U-87 MG Glioma Cell Lines.
    Marslin G; Siram K; Liu X; Khandelwal VKM; Xiaolei S; Xiang W; Franklin G
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29165384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
    Kang BS; Choi JS; Lee SE; Lee JK; Kim TH; Jang WS; Tunsirikongkon A; Kim JK; Park JS
    Carbohydr Polym; 2017 Mar; 159():39-47. PubMed ID: 28038752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model.
    Noorani L; Stenzel M; Liang R; Pourgholami MH; Morris DL
    J Nanobiotechnology; 2015 Mar; 13():25. PubMed ID: 25890381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoformulations of albendazole as effective anticancer and antiparasite agents.
    Movahedi F; Li L; Gu W; Xu ZP
    Nanomedicine (Lond); 2017 Oct; 12(20):2555-2574. PubMed ID: 28954575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles.
    Garanti T; Stasik A; Burrow AJ; Alhnan MA; Wan KW
    Int J Pharm; 2016 Mar; 500(1-2):305-15. PubMed ID: 26775062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (cRGD)2 peptides modified nanoparticles increase tumor-targeting therapeutic effects by co-delivery of albendazole and iodine-131.
    Liu S; Liu H; Sun H; Deng S; Yue L; Weng Z; Yang J; Zuo B; He Y; Zhang B
    Anticancer Drugs; 2022 Jan; 33(1):19-29. PubMed ID: 34261920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
    Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
    Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper(II) oxide nanoparticles augment antifilarial activity of Albendazole: In vitro synergistic apoptotic impact against filarial parasite Setaria cervi.
    Zafar A; Ahmad I; Ahmad A; Ahmad M
    Int J Pharm; 2016 Mar; 501(1-2):49-64. PubMed ID: 26827921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albendazole-cyclodextrin complex: enhanced cytotoxicity in ovarian cancer cells.
    Pourgholami MH; Wangoo KT; Morris DL
    Anticancer Res; 2008; 28(5A):2775-9. PubMed ID: 19035309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of in-vitro cytotoxicity and cellular uptake efficiency of zidovudine-loaded solid lipid nanoparticles modified with Aloe Vera in glioma cells.
    K S J; Sharma CP; Kalarikkal N; Sandeep K; Thomas S; Pothen LA
    Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():40-50. PubMed ID: 27207037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro evaluation of solid dispersions as strategy to improve albendazole biopharmaceutical behavior.
    Simonazzi A; Cid AG; Paredes AJ; Schofs L; Gonzo EE; Palma SD; Bermúdez JM
    Ther Deliv; 2018 Sep; 9(9):623-638. PubMed ID: 30189808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-dispersible nanocrystals of albendazole produced by high pressure homogenization and spray-drying.
    Paredes AJ; Llabot JM; Sánchez Bruni S; Allemandi D; Palma SD
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1564-70. PubMed ID: 26856301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomeric resolution of albendazole sulfoxide by semipreparative HPLC and in vitro study of growth inhibitory effects on human cancer cell lines.
    Belaz KR; Denadai M; Almeida AP; Lima RT; Vasconcelos MH; Pinto MM; Cass QB; Oliveira RV
    J Pharm Biomed Anal; 2012 Jul; 66():100-8. PubMed ID: 22487592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression.
    Saber S; Nasr M; Saad AS; Mourad AAE; Gobba NA; Shata A; Hafez AM; Elsergany RN; Elagamy HI; El-Ahwany E; Amin NA; Girgis S; Elewa YHA; Mahmoud MH; Batiha GE; El-Rous MA; Kamal I; Kaddah MMY; Khodir AE
    Biomed Pharmacother; 2021 Oct; 142():112029. PubMed ID: 34416629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
    Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
    Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
    Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
    Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors.
    Hettiarachchi G; Samanta SK; Falcinelli S; Zhang B; Moncelet D; Isaacs L; Briken V
    Mol Pharm; 2016 Mar; 13(3):809-18. PubMed ID: 26756920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy.
    Rodenak-Kladniew B; Islan GA; de Bravo MG; Durán N; Castro GR
    Colloids Surf B Biointerfaces; 2017 Jun; 154():123-132. PubMed ID: 28334689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
    Jang DJ; Moon C; Oh E
    Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effect of F-actin targeted carrier combined with antimitotic drug on aggressive colorectal cancer cytoskeleton: Allying dissimilar cell cytoskeleton disrupting mechanisms.
    Taranejoo S; Janmaleki M; Pachenari M; Seyedpour SM; Chandrasekaran R; Cheng W; Hourigan K
    Int J Pharm; 2016 Nov; 513(1-2):464-472. PubMed ID: 27662804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.